PFD report

Amelia Alexandra Anuszka RIDOUT · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 11 Feb 2025•Cambridgeshire and Peterborough

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
2

Raised in this report

Recipients
3

Named on the report

Responses found
3

Of 3 recipients

Stated actions
14

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised2

  1. Lack of national guidelines and a standard operating procedure for Bone Marrow Aspirate and trephine biopsy methodology
  2. Lack of a database to record Bone Marrow Aspirate and trephine biopsy procedures and outcomes
    Part of recurring concern: Unreliable biopsy documentation and reporting
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.5

  1. Action

    Communicate support to the British Society for Haematology for developing national bone marrow aspiration and trephine biopsy guidance.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 12 February 2025.
  2. Action

    Contribute to the BSH good practice paper on bone marrow aspirate and trephine biopsy, including applicable NICE references, and liaise with BSH and NHS England during its development.

    Stated by National Institute for Health and Care ExcellenceStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.
  3. Action

    Review literature and evidence on adverse outcomes and safest techniques for bone marrow aspirate and trephine biopsy in adults and children.

    Stated by British Society for HaematologyStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.5

  1. Position

    Developing national clinical guidelines or SOPs for bone marrow aspiration and trephine biopsy falls outside NHS England’s remit.

    Stated by NHS EnglandOutside remitThe respondent said that this matter was outside its role or authority.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of national guidelines and a standard operating procedure for Bone Marrow Aspirate and trephine biopsy methodology

Wider context from the report

“To consider the development and publication of a national guidelines and standard operating procedure for the carrying out of Bone Marrow Aspirate (BMA) and trephine biopsy to include recommended methodology. ”

Is this part of a recurring concern?

No recurring-concern membership is currently published.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of a database to record Bone Marrow Aspirate and trephine biopsy procedures and outcomes

Wider context from the report

“To consider the development of a data base to record these procedures and their outcomes. ”

Is this part of a recurring concern?

Yes — Unreliable biopsy documentation and reporting.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Communicate support to the British Society for Haematology for developing national bone marrow aspiration and trephine biopsy guidance.

Verbatim wording from the response

“NHS England have however communicated to the BSH that it would be supportive of them developing the relevant national guidance for clinicians. Our national Patient Safety Team have advised that they would consider issuing a National Patient Safety Alert (NatPSA) to support awareness of key recommendations, although this would have to be weighed against the existing NatPSA criteria. We are aware that the BSH has already published a demonstration video on ‘How to perform bone marrow aspiration and trephine biopsy’.”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Contribute to the BSH good practice paper on bone marrow aspirate and trephine biopsy, including applicable NICE references, and liaise with BSH and NHS England during its development.

Verbatim wording from the response

“We note that you have also written to the British Society for Haematology (BSH) and NHS England and as part of our process, our consultant clinical advisors have been in communication with these two organisations and will contribute as needed in the production of a good practice paper for bone marrow aspirate and trephine biopsy, which is being led by the BSH.”

Source location

Response from NICE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review literature and evidence on adverse outcomes and safest techniques for bone marrow aspirate and trephine biopsy in adults and children.

Verbatim wording from the response

“3. Review the literature and evidence regarding adverse outcomes after bone marrow aspirate and trephine biopsy on adults and children, and safest techniques.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Explore developing a registry of complications to inform future guidance.

Verbatim wording from the response

“6. Explore the possibility of developing a registry of complications to inform future guidelines.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Develop national guidance on bone marrow procedure methodology, training and competency assessment using the gathered evidence.

Verbatim wording from the response

“4. With these sources of information, develop a national guideline for recommended methodology and include recommendations for training and competency assessment.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Developing national clinical guidelines or SOPs for bone marrow aspiration and trephine biopsy falls outside NHS England’s remit.

Verbatim wording from the response

“It would not sit within the remit of NHS England to produce the relevant clinical guidelines or SOP for BMA and trephine biopsy, although we have engaged with the National Institute for Health and Care Excellence (NICE) and the British Society for Haematology (BSH) on the concerns raised in HM Coroner’s Report and have been sighted on the responses from NICE and the BSH to the Coroner.”

Source location

Response from NHSE
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

NHS England does not consider developing a registry for bone marrow aspiration and trephine biopsy necessary at this point.

Verbatim wording from the response

“Regarding the development of a database to record BMA and trephine biopsy procedures and their outcomes, my colleagues with responsibility for national databases and registries have considered this, together with your Report. NHS England do not consider there is a need for us to develop a registry at this point, however we will undertake to:”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The British Society for Haematology, as the responsible professional society, is undertaking relevant guidance and procedure-safety work.

Verbatim wording from the response

“We also note many of the actions being undertaken by the BSH, as the responsible professional society for the procedure, and outlined in their response to you which include improving existing consent processes, their exploration of the possibility of a registry of complications and establishing an audit process for Trusts.”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

The British Society for Haematology is leading development of the good practice paper on bone marrow aspirate and trephine biopsy.

Verbatim wording from the response

“We note that you have also written to the British Society for Haematology (BSH) and NHS England and as part of our process, our consultant clinical advisors have been in communication with these two organisations and will contribute as needed in the production of a good practice paper for bone marrow aspirate and trephine biopsy, which is being led by the BSH.”

Source location

Response from NICE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Producing detailed guidance on how clinicians should perform standard bone marrow procedures is outside the organisation’s remit.

Verbatim wording from the response

“This is a truly tragic outcome from a widely used intervention that is essential in haematological practice. Bleeding due to vascular injuries is recognised as a rare, but possible adverse outcome of the procedure. NICE have not published any specific procedural guidance on bone marrow aspirate and trephine biopsy however, NICE guidance refers to the need to carry out the procedure for diagnosis¹. NICE are not asked to develop guidance on all conditions and our recommendations do not cover all clinical circumstances. Our guidance focuses on the management and treatment of conditions and although we may outline recommendations on when an investigation or diagnostic test is necessary, it is not within our remit to produce detailed guidance on how clinicians should carry out a standard diagnostic procedure.”

Source location

Response from NICE
Page 1 · response
Published 12 February 2025

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.9

  1. 1

    Investigate evidence on bone marrow procedures to identify potential root causes, including training and supervision issues.

    Stated by NHS EnglandStated plannedThe respondent said that this action was planned when they made their response on 12 February 2025.
  2. 2

    Make East of England regional Clinical Quality colleagues aware of the Report and circumstances surrounding the death.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 12 February 2025.
  3. 3

    Share the Report’s learning and insights across NHS national and regional levels through the Regulation 28 Working Group.

    Stated by NHS EnglandStated completedThe respondent said that this action was complete when they made their response on 12 February 2025.
  4. 4

    Review relevant national guidance and assess how it translates into local policies.

    Stated by NHS EnglandStated plannedThe respondent said that this action was planned when they made their response on 12 February 2025.
  5. 5

    Name the recommended bone marrow procedure method “Millie’s method.”

    Stated by British Society for HaematologyStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.
  6. 6

    Improve consent processes to include the rare risk of death and incorporate the change into national guidance.

    Stated by British Society for HaematologyStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.
  7. 7

    Survey trainee haematologists about training, competency and support for performing bone marrow procedures in adults and children.

    Stated by British Society for HaematologyStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.
  8. 8

    Establish an audit process enabling Trusts to monitor performance and implementation of national guidance.

    Stated by British Society for HaematologyStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.
  9. 9

    Survey adult patients and parents of children about their experiences of receiving bone marrow procedures.

    Stated by British Society for HaematologyStated in progressThe respondent said that this action was in progress when they made their response on 12 February 2025.

Recipient positions A position is what a recipient says about a concern when they do not describe a specific action.1

  1. 1

    Integrated Care Boards commission these procedures and should ensure Hospital Trusts have appropriate processes for safe and effective delivery.

    Stated by NHS EnglandRedirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Investigate evidence on bone marrow procedures to identify potential root causes, including training and supervision issues.

Verbatim wording from the response

“Regarding the development of a database to record BMA and trephine biopsy procedures and their outcomes, my colleagues with responsibility for national databases and registries have considered this, together with your Report. NHS England do not consider there is a need for us to develop a registry at this point, however we will undertake to:”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Make East of England regional Clinical Quality colleagues aware of the Report and circumstances surrounding the death.

Verbatim wording from the response

“for the East of England have been made aware of your Report and the circumstances that led to Amelia’s death, and they can liaise with the local ICB directly.”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Share the Report’s learning and insights across NHS national and regional levels through the Regulation 28 Working Group.

Verbatim wording from the response

“I would also like to provide further assurances on the national NHS England work taking place around the Reports to Prevent Future Deaths. All reports received are discussed by the Regulation 28 Working Group, comprising Regional Medical Directors, and other clinical and quality colleagues from across the regions. This ensures that key learnings and insights around events, such as the sad death of Amelia, are shared across the NHS at both a national and regional level and helps us to pay close attention to any emerging trends that may require further review and action.”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review relevant national guidance and assess how it translates into local policies.

Verbatim wording from the response

“Regarding the development of a database to record BMA and trephine biopsy procedures and their outcomes, my colleagues with responsibility for national databases and registries have considered this, together with your Report. NHS England do not consider there is a need for us to develop a registry at this point, however we will undertake to:”

Source location

Response from NHSE
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Name the recommended bone marrow procedure method “Millie’s method.”

Verbatim wording from the response

“8. Name the recommended method Millie’s method, in accordance with Mr Ridout’s request.”

Source location

Response from British Society for Haematology
Page 2 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Improve consent processes to include the rare risk of death and incorporate the change into national guidance.

Verbatim wording from the response

“5. Improve existing consent processes to include the rare risk of death and add these to the guideline.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Survey trainee haematologists about training, competency and support for performing bone marrow procedures in adults and children.

Verbatim wording from the response

“1. Gather data, via survey to trainee haematologists, to understand the training, competencies and support they receive in undertaking this procedure, both for adults and children.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Establish an audit process enabling Trusts to monitor performance and implementation of national guidance.

Verbatim wording from the response

“7. Establish an audit process for Trusts to monitor their performance and ensure proper implementation of national guidance.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Survey adult patients and parents of children about their experiences of receiving bone marrow procedures.

Verbatim wording from the response

“2. Gather data, via a Blood Cancer UK survey, on experiences of adult patients and parents of children who have received the procedure.”

Source location

Response from British Society for Haematology
Page 1 · response
Published 12 February 2025

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Integrated Care Boards commission these procedures and should ensure Hospital Trusts have appropriate processes for safe and effective delivery.

Verbatim wording from the response

“BMA and trephine biopsy are common diagnostic procedures, used for a variety of reasons. Our National Specialty Advisor for Blood and Marrow Transplantation (BMT) has considered your Report and confirmed that the procedures do not sit within the NHS England commissioned BMT pathway or within specialised children’s services. It is therefore a service directly commissioned by Integrated Care Boards (ICBs), who would be expected to ensure that Hospital Trusts have the appropriate processes in place to deliver the procedure safely and effectively. The Coroner may wish to engage with the relevant ICB in this matter, although my regional Clinical Quality colleagues”

Source location

Response from NHSE
Page 1 · response
Published 12 February 2025

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
3/3

Data last updated 7 September 2026